Arlene Morris

Ms. Arlene M.
Morris is an Independent Director at Edgewise Therapeutics, Inc., a Chairman at TC Biopharm (Holdings) Plc, an Independent Director at Cogent Biosciences, Inc., an Independent Director at Viridian Therapeutics, Inc., an Independent Director at Viveve, Inc., an Independent Director at Palatin Technologies, Inc., a Chief Executive Officer at Willow Advisors LLC and a Chairman-Research & Development Foundation at Medical University of South Carolina Foundation.
She is on the Board of Directors at Edgewise Therapeutics, Inc., Charleston Animal Society, Cogent Biosciences, Inc., Viridian Therapeutics, Inc., Viveve, Inc. and Palatin Technologies, Inc. Ms. Morris was previously employed as a Trustee by Carlow University Of, an Independent Director by Viveve Medical, Inc., an Independent Director by Dimension Therapeutics, Inc., an Independent Director by Neovacs SA, a President, Chief Executive Officer & Director by Syndax Pharmaceuticals, Inc., an Independent Director by MediciNova, Inc., a President, Chief Executive Officer & Director by Affymax, Inc., a President & Chief Executive Officer by Clearview Projects, Inc., a Senior Vice President-Business Development by Coulter Pharmaceuticals, Inc., a Senior Vice President-Business Development by Scios, Inc., a Vice President-Business Development by Johnson & Johnson, and a Chairman by Nuon Therapeutics, Inc. She also served on the board at Biodel, Inc., MUSC Foundation for Research Development, Neovacs, Inc., Humane Society of Silicon Valley and Biotechnology Industry Organization.
She received her undergraduate degree from Carlow College and an undergraduate degree from Western New England University.